Testing and Monitoring

Displaying 11 - 20 of 178

Pacemaker firmware update addresses vulnerabilities

Pacemaker firmware update addresses vulnerabilities
Abbott has notified physicians of updates to its implantable pacemakers and defibrillators as part of its ongoing commitment to continuously improve patient care. The new device updates include a Battery Performance Alert for our implantable cardioverter defibrillators (ICDs) that provides physicians with earlier warning of the potential for the low risk of premature battery depletion.
1st September 2017

Motorised molecules drill through cells

Motorised molecules drill through cells
Motorised molecules driven by light have been used to drill holes in the membranes of individual cells and show promise for either bringing therapeutic agents into the cells or directly inducing the cells to die. Researchers at Rice, Durham (U.K.) and North Carolina State universities demonstrated in lab tests how rotors in single-molecule nanomachines can be activated by ultraviolet light to spin at 2 to 3 million rotations per second and open membranes in cells.
1st September 2017

Photoacoustics measures oxygenation of tumours

Photoacoustics measures oxygenation of tumours
A new imaging technique uncovers oxygen levels in prostate tumours and could lead to a non-invasive way to determine which tumours are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics. Scientists at the University of Cambridge created a new technique with an imaging device using a combination of light and sound to check the oxygen levels in prostate tumours in mice.
30th August 2017


Hepatocellular carcinoma test can be administered anywhere

Hepatocellular carcinoma test can be administered anywhere
  It’s estimated that about 788,000 people worldwide died of liver cancer in 2015, the second-leading cause of cancer deaths, according to the latest statistics from the World Health Organization. One of the major challenges in combatting this disease is detecting it early because symptoms often don’t appear until later stages.
29th August 2017

Ultra-high MRI scanner receives EU Approval

Ultra-high MRI scanner receives EU Approval
Siemens Healthineers has just won the first European regulatory approval for an ultra-high-field MRI scanner to be used in clinical practice. The Magnetom Terra sports a magnetic field strength of 7 Tesla, which is considerably more powerful than 3 Tesla, the current high-end standard. MRIs of such strength have been used in research hospitals for years, so it’s a welcome sign that they’re going to be used in more routine applications.
29th August 2017

'Body-on-a-chip' helps discover side effects of drugs

'Body-on-a-chip' helps discover side effects of drugs
Researchers at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) in Japan have designed a small 'body-on-a-chip' device that can test the side effects of drugs s on human cells. The device solves some issues with current, similar microfluidic devices and offers promise for the next generation of pre-clinical drug tests. The Integrated Heart/Cancer on a Chip (iHCC) was used to test the toxicity of the anti-cancer drug doxorubicin on heart cells.
29th August 2017

Low noise amplifiers feature noise figure as low as 0.4dB

Low noise amplifiers feature noise figure as low as 0.4dB
A product family of low noise amplifiers (LNAs) from WanTcom is available at Richardson RFOPD with full design support capabilities. The family of LNAs feature WanTcom's proprietary low noise amplifier technologies, high frequency microelectronics assembly techniques, and long-standing reputation for high-reliability.
24th August 2017

Therapy pacemaker receives FDA Approval

Therapy pacemaker receives FDA Approval
BIOTRONIK has announced FDA approval and commercial availability of Edora HF-T QP, an MR conditional quadripolar (QP) cardiac resynchronisation therapy pacemaker (CRT-P) with MRI AutoDetect technology. With a volume of 15 cc, Edora HF-T QP is the smallest MR conditional CRT-P available in the US with longevity of nearly 10 years, reducing the frequency of device replacements for heart failure patients.
24th August 2017

Attain Stability Quad MRI SureScan receives CE Mark

Attain Stability Quad MRI SureScan receives CE Mark
Medtronic has announced it has received CE Mark for the Attain Stability Quad MRI SureScan left heart lead. Paired with Medtronic quadripolar cardiac resynchronisation therapy-defibrillators (CRT-D) and -pacemakers (CRT-P), the Attain Stability Quad lead features novel, active-fixation technology that is designed for precise lead placement and stability. In the United States, the Attain Stability Quad lead is under evaluation in a clinical trial and is not approved for sale.
24th August 2017

Gut-on-a-chip tech to study toxicology, transport, and disease

Gut-on-a-chip tech to study toxicology, transport, and disease
  MIMETAS, in collaboration with the pharmaceutical company Roche (Basel), has developed a novel organ-on-a-chip system that supports evaluation of intestinal permeability in perfused 3D gut tubules in high throughput. The results of this research were published in the scientific journal Nature Communications.
22nd August 2017


Testing and Monitoring documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

PPMA Show 2017
26th September 2017
United Kingdom NEC, Birmingham
World’s top 50 innovators from the industries of the future
27th September 2017
United Kingdom London
New Scientist Live 2017
28th September 2017
United Kingdom Excel, London
Kiosk Summit 2017
28th September 2017
United Kingdom London
act! 2017
28th September 2017
Germany NHOW Berlin